Kodiak Sciences (KOD) Accumulated Depreciation (2017 - 2025)
Kodiak Sciences (KOD) reported Accumulated Depreciation of $59.5 million for Q4 2025, up 44.13% on a YoY basis from $41.3 million in Q4 2024, and up 44.13% quarter-over-quarter from $41.3 million in Q4 2024.
Kodiak Sciences (KOD) Accumulated Depreciation (2017 - 2025) Analysis & Trends
Kodiak Sciences has reported Accumulated Depreciation for 9 years, with the latest figure at $59.5 million in Q4 2025.
- For the quarter ending Q4 2025, Accumulated Depreciation rose 44.13% year-over-year to $59.5 million; the trailing twelve-month figure through Dec 2025 stood at $59.5 million (up 44.13% YoY), and the FY2025 full-year result was $59.5 million, up 44.13% from the prior year.
- Accumulated Depreciation for Q4 2025 stood at $59.5 million, up from $41.3 million in the prior quarter.
- The five-year high for Accumulated Depreciation was $59.5 million in Q4 2025, with the low at $2.9 million in Q4 2021.
- Historically, Accumulated Depreciation has averaged $26.6 million across 5 years, with a median of $22.6 million in 2023.
- Annual changes were most pronounced in 2021 — Accumulated Depreciation surged 35.44% — and 2023, when it surged 235.4%.
- Kodiak Sciences' Accumulated Depreciation stood at $2.9 million in 2021, then surged by 128.79% to $6.7 million in 2022, then surged by 235.4% to $22.6 million in 2023, then jumped by 82.96% to $41.3 million in 2024, then jumped by 44.13% to $59.5 million in 2025.
- The last three Accumulated Depreciation figures came in at $59.5 million (Q4 2025), $41.3 million (Q4 2024), and $22.6 million (Q4 2023), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - |
| 10 | Kodiak Sciences | 1.95 Bn | 1.95 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 59.47 Mn |
| Dec 31, 2024 | 41.26 Mn |
| Dec 31, 2023 | 22.55 Mn |
| Dec 31, 2022 | 6.72 Mn |
| Dec 31, 2021 | 2.94 Mn |
| Dec 31, 2020 | 2.17 Mn |
| Dec 31, 2019 | 1.77 Mn |
| Dec 31, 2018 | 1.69 Mn |
| Sep 30, 2018 | 1.82 Mn |
| Dec 31, 2017 | 1.45 Mn |